The parent company of JSR Life Sciences snapped up CRO Crown Bioscience International for $400M, the company announced this morning. Source: BioSpace

Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 magnetic beads as part of the clinical and commercial manufacturing processes for its…

Baillie Gifford and ORI Capital co-led the financing with significant new investments from Temasek and Cowen Healthcare Investments, alongside Juda Capital, Pavilion Capital, RTW Investments, Agent Capital, 4BIO Capital and…

Five Prime and Zai Lab today announced an exclusive license agreement for FPA144 in Greater China and global strategic development collaboration. Source: BioSpace

Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace

The total capital raised by Flagship to fuel its institutional innovation and venture creation platform now exceeds $2.3B. Source: BioSpace

The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace

An experimental treatment to address cognitive impairment in pediatric patients diagnosed with the rare disease known as Hunter syndrome failed a key trial, Shire PLC announced this morning. Source: BioSpace

Roche's patent dispute with Shire over the new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some…

Cue BioPharma is on a roll, having recently signed a deal with Merck and is planning an IPO to raise up to $60M. Source: BioSpace